These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30071276)

  • 21. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
    Scott J; Jones AM; Piper Hanley K; Athwal VS
    Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
    Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
    Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic modifiers of liver disease in cystic fibrosis.
    Bartlett JR; Friedman KJ; Ling SC; Pace RG; Bell SC; Bourke B; Castaldo G; Castellani C; Cipolli M; Colombo C; Colombo JL; Debray D; Fernandez A; Lacaille F; Macek M; Rowland M; Salvatore F; Taylor CJ; Wainwright C; Wilschanski M; Zemková D; Hannah WB; Phillips MJ; Corey M; Zielenski J; Dorfman R; Wang Y; Zou F; Silverman LM; Drumm ML; Wright FA; Lange EM; Durie PR; Knowles MR;
    JAMA; 2009 Sep; 302(10):1076-83. PubMed ID: 19738092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
    Martin CR; Zaman MM; Ketwaroo GA; Bhutta AQ; Coronel E; Popov Y; Schuppan D; Freedman SD
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G474-81. PubMed ID: 22679000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
    Pereira TN; Lewindon PJ; Greer RM; Hoskins AC; Williamson RM; Shepherd RW; Ramm GA
    J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New treatments targeting the basic defects in cystic fibrosis.
    Fajac I; Wainwright CE
    Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation.
    Shen H; Fan Y; Yang X; Burczynski FJ; Li P; Gong Y
    J Cell Physiol; 2005 Jun; 203(3):599-603. PubMed ID: 15605366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of cftr function leads to pancreatic destruction in larval zebrafish.
    Navis A; Bagnat M
    Dev Biol; 2015 Mar; 399(2):237-48. PubMed ID: 25592226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
    Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
    Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic Fibrosis-related Liver Disease: The Next Challenge.
    Baker RD; Baker SS
    J Pediatr Gastroenterol Nutr; 2020 Oct; 71(4):421-422. PubMed ID: 32740535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
    Jiang Q; Engelhardt JF
    Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models.
    Wang Y; Wrennall JA; Cai Z; Li H; Sheppard DN
    Int J Biochem Cell Biol; 2014 Jul; 52():47-57. PubMed ID: 24727426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
    van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
    Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver and biliary problems in cystic fibrosis.
    Colombo C; Battezzati PM; Strazzabosco M; Podda M
    Semin Liver Dis; 1998; 18(3):227-35. PubMed ID: 9773423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
    Barrio R
    Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis.
    Sathe MN; Freeman AJ
    Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.